Small molecule-based Lifespan extension therapy: Leucine may prolong mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 12/April/2014, 23.35

Vitamin-based therapy stalls metastatic Prostate cancer spread: Vitamin-E (α-Tocopherol) suppresses GATA2-IGF2 axis and halts the progression of prostate cancer, 12/April/2015, 23.18
April 12, 2015
Small molecule-based Lifespan extension therapy: Neurotensin increases life span via up regulation of its target gene BubR1, 12/April/2015, 23.51
April 12, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, L., Small molecule-based Lifespan extension therapy: Leucine may prolong mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 12/April/2014, 23.35, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: It has been shown earlier that angiotensin II type I receptor (AT1R) antagonist prolongs mammalian life span. This study suggests, for the first time, that  Leucine, by increasing the expression of its target gene,  it may suppress the expression of AT1R. And thereby, it may (1) decrease blood pressure; and (2) and extend the lifespan of an individual. Thus, pharmacological formulations encompassing “Leucine or its analogues” may be used to extend the life-span of an individual.

Undisclosed information: How Leucine suppresses the expression of  angiotensin II type I receptor (AT1R)

Comments are closed.